Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Covington
Cipla
Baxter
McKesson
Teva
US Army
Queensland Health

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091441

« Back to Dashboard

NDA 091441 describes NARATRIPTAN, which is a drug marketed by Apotex Corp, Casi Pharms Inc, Heritage Pharms Inc, Mylan Pharms Inc, Orchid Hlthcare, Paddock Llc, Sun Pharm Inds Ltd, Teva Pharms, and West-ward Pharms Int, and is included in nine NDAs. It is available from five suppliers. Additional details are available on the NARATRIPTAN profile page.

The generic ingredient in NARATRIPTAN is naratriptan hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.
Summary for 091441
Tradename:NARATRIPTAN
Applicant:Orchid Hlthcare
Ingredient:naratriptan hydrochloride
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 091441
Suppliers and Packaging for NDA: 091441
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091441 ANDA OrchidPharma, Inc 42043-130 N 42043-130-09
NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091441 ANDA OrchidPharma, Inc 42043-131 N 42043-131-09

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Apr 30, 2012TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2.5MG BASE
Approval Date:Apr 30, 2012TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Johnson and Johnson
Medtronic
Farmers Insurance
Citi
Queensland Health
Deloitte
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.